Related Experiment Video
Updated: Sep 26, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
Multi-species assessment of propranolol pharmacokinetics via minimal and whole-body PBPK modeling
Minsoo Lee1, Min Ji Ji1, Yoo-Seong Jeong1
1College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea.
Abstract:
Propranolol is a widely-used β-adrenergic blocker with extensive pharmacokinetic (PK) data across multiple species, rendering it appropriate for comparing various interspecies scaling methodologies. The present study aimed to apply a quantitative interspecies PK modeling framework for propranolol using literature-derived datasets from seven mammalian species, namely, mouse, rat, rabbit, cat, dog, human, and horse. Conventional allometric analyses indicated body weight-dependent relationships for both clearance and steady-state volume of distribution. For the top-down minimal physiologically-based pharmacokinetic (mPBPK) modeling approach, the model incorporated two peripheral tissue compartments governed by shared distribution parameters across different species. The simultaneous fitting of intravenous (IV) propranolol PK data from seven species to the mPBPK model produced parameter estimates that reasonably captured the observed plasma PK data. Subsequent individual fitting of IV and oral propranolol PK data for each species adequately estimated additional absorption-related parameters. To improve physiological interpretability, top-down parameter estimates were aligned with bottom-up whole-body PBPK parameters via tissue-lumping principles. A unitless product-ratio plot further provided species-dependent kinetic distinctions on the biological half-lives of propranolol. Finally, translational performance was evaluated by scaling preclinical datasets, where the mPBPK model derived from three common preclinical species provided reasonable predictions of human IV PK profiles. Collectively, these findings provide a clearer physiological interpretation of propranolol disposition across species. Building upon the previous efforts using mPBPK modeling, the current study demonstrates a more mechanistically informed, refined workflow for interspecies scaling and translational human PK prediction applicable to drug candidates.
More Related Videos
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020
08:28Microsurgical Skills of Establishing Permanent Jugular Vein Cannulation in Rats for Serial Blood Sampling of Orally Administered Drug
Published on: December 14, 2021
Related Concept Videos
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion, mediated...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Physiological Pharmacokinetic Models: Assumption with Protein Binding
Analysis of Population Pharmacokinetic Data
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...